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Fig. S1. Hemolytic and CAMP factor activity of two rectovaginal GBS isolates. Fig. S8 . The GBS pigment and hyperpigmented GBS induce the release of the cytosolic enzyme LDH from PCMCs, similar to the Ca 2+ ionophore. Fig. S9 . Hyperpigmented GBS wild-type NCTC10/84 induces mast cell degranulation in vivo in a hemolytic pigment-dependent manner. Fig. S10 . In vivo mast cell degranulation by hyperpigmented GBS∆covS. Fig. S11 . Bacterial burden and levels of cytokines, neutrophils, and histamine in peritoneal fluids obtained from mast cell-deficient and mast cell-proficient mice during systemic GBS infection. Fig. S12 . Cytokine IL-4 levels were not significantly increased in spleens of mast cell-proficient or mast cell-deficient mice infected with hyperpigmented GBS. Fig. S13 . Basophil-depleted mice exhibit similar bacterial burden and levels of histamine and cytokines during systemic infection with hyperpigmented GBS. Fig. S14 . Decreased vaginal colonization of GBS NCTC10/84 in wild-type mice. Figure S1 . Hemolytic and CAMP factor activity of two rectovaginal GBS isolates. (A) shows hemolytic activity represented by zone of clearing around the colonies on blood agar (B) shows CAMP factor activity which is represented by the triangular zone of lysis seen at the junction between GBS and β toxin producing S. aureus. COH1 is a wild type (WT) GBS clinical isolate from an infected newborn and belongs to the hypervirulent ST-17 clone. COH1ΔcovR is a mutant derived from COH1 and exhibits increased hemolytic activity. Strains 65 and 91 are rectovaginal GBS isolates that exhibit increased hemolysis and decreased CAMP factor expression similar to COH1ΔcovR. Figure S2 . FACS (fluorescence-activated cell sorting) characterization of PCMCs. Flow cytometry was used to characterize the phenotype of peritoneal mast cells (PCMC) generated in vitro. Cells were stained with PE conjugated anti-FcεR1 and APC-Cy7 conjugated anti-cKit (CD117). Note that greater than 90% of the peritoneal mast cells are FcεR1 + cKit + . Figure S3 . Mast cells release β-hex in a hemolytic pigment dependent manner. Approximately 10 5 mast cells (BMCMCs or PCMCs) were treated with hemolytic GBS pigment (5 µM, see A), or with 10 7 CFU of natively hyperpigmented GBS NCTC10/84 (see B) or GBS ΔcovS (see C for hemolysis (blood agar plate) and pigment expression (granada media) and D for β-hex release). As respective controls, mast cells were either treated with an equivalent amount of non-hemolytic pigment (i.e. pigment lacking the carrier molecule starch, see A) or with 10 7 CFU of non-pigmented GBS such as NCTC10/84ΔcylE (see B) or GBS ΔcovSΔcyl (see C for absence of hemolytic pigment & D for β-hex release). Controls for pigment included the ΔcylE extract and buffer DT (DMSO+0.1%TFA) with and without starch (see A). DTS refers to DMS0+0.1% TFA+20% starch. Uninfected mast cells (UI) served as negative control and the Ca 2+ ionophore A23187 (5 µM) was included as a positive control for mast cell degranulation. β-hexosaminidase release was measured 1 hr after treatment. Data shown were obtained from three independent experiments performed in duplicate and were compared to uninfected mast cells (n=3, * p < 0.05, ** p < 0.01, NS = p > 0.9, Bonferroni's multiple comparison test following ANOVA, error bars ± s.e.m.).
A.
B.
C. D. BMCMCs derived from NLRP3KO mice were treated with GBS (WT A909) and isogenic strains such as hyperhemolytic ΔcovR or non-hemolytic ΔcovRΔcylE or ΔcylE strains or with purified GBS pigment (2.5µM). Negative controls included uninfected mast cells (UI), equal amounts of extract from the non-pigmented ΔcylE strain, and buffer DTS (DMS0+0.1% TFA+20% starch). The Ca 2+ ionophore A23187 (5µM) was included as a positive control for mast cell degranulation. β-hexosaminidase release was measured 1 hr after treatment (n=3, * p < 0.05, *** p < 0.001, Bonferroni's multiple comparison test following ANOVA, error bars ± s.e.m.). 5 PCMCs were treated with hemolytic GBS pigment (0.625 µM, see A, C) or with 10 7 CFU of natively hyperpigmented WT GBS NCTC10/84 (see B, D). As respective controls, mast cells were either treated with an equivalent amount of non-hemolytic pigment (i.e. pigment lacking the carrier molecule starch, see A, C) or with 10 7 CFU of non-pigmented GBS NCTC10/84ΔcylE (see B, D). Controls for pigment included the ΔcylE extract and buffer DT (DMSO+0.1%TFA) with and without starch (see A, C). DTS refers to DMS0+0.1% TFA+20% starch. Uninfected mast cells (UI) served as negative control. Release of leukotriene C4 (LTC 4 ) and prostaglandin D2 (PGD 2 ) was measured as described in materials and methods. Data shown were obtained from three independent experiments and were compared to uninfected cells (UI) using Bonferroni's or Dunnett's multiple comparison test following ANOVA (n=3, * p < 0.05, ** p < 0.01, NS = p ≥ 0.9, error bars ± s.e.m.).
C. D. 5 mast cells (PCMCs) were exposed to GBS pigment (2.5 µM) or equivalent amount of control ΔcylE extract and the release of the β-hexosaminidase (β-hex) was measured over time. Data shown were obtained from three independent experiments performed in duplicate and were compared to time at t = 0 min (n=3, * p <0.05, **p <0.01, ****p <0.0001, Dunnett's multiple comparison test following ANOVA, error bars ± s.e.m.). Figure S8 . The GBS pigment and hyperpigmented GBS induce the release of the cytosolic enzyme LDH from PCMCs, similar to the Ca2 + ionophore. Approximately 10 5 mast cells (PCMCs) were exposed to (A) GBS pigment (0.15-2.5 µM) or controls (ΔcylE extract, buffer DTS, 5µM Ca 2+ ionophore A23187), or (B) 10 7 CFU of GBS strains and the release of the cytoplasmic enzyme lactate dehydrogenase (LDH) was measured after 1hr. Data shown were obtained from two independent experiments performed in duplicate and release of LDH was compared to DTS control for (A) or uninfected mast cells for (B); *p <0.05, **p <0.01, ****p <0.0001, Dunnett's multiple comparison test following ANOVA, error bars ± s.e.m.).
B. Figure S9 . Hyperpigmented GBS wild-type NCTC10/84 induces mast cell degranulation in vivo in a hemolytic pigment dependent manner. WT C57BL6/J mice (n=6/group) were infected I.P. with 10 7 CFU of WT NCTC10/84. Controls included isogenic non-pigmented NCTC10/84ΔcylE. Peritoneal fluid was collected at 2hrs post infection and peritoneal cells were cyto-centrifuged and stained with May-Grünwald-Giemsa. Representative images at 100X magnification show intact mast cells (NCTC10/84ΔcylE) and activated mast cells (see NCTC10/84) were scored in a blinded fashion as described previously (**p < 0.01 Mann Whitney test). Histamine levels are shown (* p < 0.05).
NCTC10/84ΔcylE NCTC10/84 B. C. Figure S10 . In vivo mast cell degranulation by hyperpigmented GBSΔcovS. Approx. 10 7 CFU of hyperpigmented GBSA909ΔcovS were infected I.P in WT C57BL6/J mice (n=6/group). Controls included mice infected with isogenic non-pigmented ΔcovSΔcyl. At 2hrs post infection, peritoneal fluid and blood were collected. Peritoneal cells were cyto-centrifuged and stained with May-Grünwald-Giemsa. Representative images at 100X magnification show intact mast cells (ΔcovSΔcyl) and activated mast cells (see ΔcovS) scored in a blinded fashion (**p < 0.01 Mann Whitney test). Histamine levels are also shown (* p < 0.05).
ΔcovSΔcyl ΔcovS B. C. Figure S12 . Cytokine IL-4 levels were not significantly increased in spleens of mast cell-proficient or mast cell-deficient mice infected with hyperpigmented GBS. Mast cell deficient mice and mast cell proficient littermate controls were infected I.P. with GBSΔcovR and control ΔcovRΔcylE. At 24 hrs post infection, cytokine IL-4 levels were measured in infected spleens. The limit of detection for the IL-4 ELISA was 3.5 pg/ml and samples that were below the limit of detection were ascribed a value at the limit of detection i.e. 3.5 pg/ml. Data shown is a representative experiment of 2 independent experiments (n=7/group, NS = p > 0.08, Bonferroni's multiple comparison test following ANOVA). Medians are shown. Figure S13 . Basophil depleted mice exhibit similar bacterial burden and levels of histamine and cytokines during systemic infection with hyperpigmented GBS. 
